Goodbody Health LTD. (GDBYF)

[drmaddogs2]

DragonFly and the other U.K. paricipators and those wishing to participate in the U.K. markets(like Aurora, Dragonfly,
Charlottesweb, Columbia Care, Mile High.. etcetera.. are using another avenue in line with Novel Foods/E.U. desired guidelines so to be hitting regulation from both directions at the same time.

The new Association for the Cannabinoid Industry (ACI)(https://www.theaci.co.uk/our-members/) is made up of roughly 25 companies from Europe and North America. The companies vow to “foster full compliance” with European Union rules that say CBD shouldn’t be sold as a food ingredient without first having premarketing authorization because CBD is a “novel food.”

ACI’s parent group, is the London-based Centre For Medicinal Cannabis (CMC), the commitment of ACI members to apply for
authorization could ease enforcement against member companies selling CBD. In addition to applying for authorization, ACI members have committed to eliminating detectable THC and adhering to testing and labeling standards and marketing ethics.... which is just like the afformentioned.. Cannabis Trades Association (CTA)(Primarily based in the U.K.) is the said 2nd tier to European Industrial Hemp Association(EIHA)(1000 membership).

The ACI Charter, is working towards the introduction of a kitemark(Kitemark is a UK product and service quality trade mark which is
owned and operated by The British Standards Institution) to display on CBD products to provide consumers with reassurance that their purchase is meeting the regulations and the CTA group both have Dragonfly Biosciences as members to move whatever process of.....

regulation is most preffered in the U.K...

One estimate says that the CBD market will generate $20 billion by 2024; another argues that this study is, in fact, too
conservative, and that CBD will actually hit $22 billion by 2022. Which ever sum total... Still is Dragonfly's Isolate supplier and

......will get a portion of those revenues.